Clinical Trial Update: A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and long-term safety of oral ozanimod in Chinese participants with moderately to severely active ulcerative col…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Ozanimod (ozanimod)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Ulcerative Colitis | Phase 3 | Status: TERMINATED